BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10430092)

  • 21. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
    Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
    Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M; Dhat R; Price CM
    Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
    Zhou M; Gu L; Yeager AM; Findley HW
    Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
    Larsen CJ
    Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
    Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
    Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletions of the p16 gene in pediatric leukemia and corresponding cell lines.
    Kees UR; Ranford PR; Hatzis M
    Oncogene; 1996 May; 12(10):2235-9. PubMed ID: 8668350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
    Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
    Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
    Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allelotype analysis of childhood acute lymphoblastic leukemia.
    Takeuchi S; Bartram CR; Wada M; Reiter A; Hatta Y; Seriu T; Lee E; Miller CW; Miyoshi I; Koeffler HP
    Cancer Res; 1995 Nov; 55(22):5377-82. PubMed ID: 7585604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
    Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
    Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia.
    Maloney KW; Rubnitz JE; Cleary ML; Frankel LS; Hakami N; Link MP; Pullen DJ; Hunger SP
    Leukemia; 1997 Jul; 11(7):979-83. PubMed ID: 9204978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene.
    Della Valle V; Duro D; Bernard O; Larsen CJ
    Oncogene; 1997 Nov; 15(20):2475-81. PubMed ID: 9395243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FISH analysis of translocations involving the short arm of chromosome 9 in lymphoid malignancies.
    Leblanc T; Derré J; Flexor M; Le Coniat M; Leroux D; Rimokh R; Larsen CJ; Berger R
    Genes Chromosomes Cancer; 1997 Aug; 19(4):273-7. PubMed ID: 9258663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletions of interferon genes in acute lymphoblastic leukemia.
    Diaz MO; Rubin CM; Harden A; Ziemin S; Larson RA; Le Beau MM; Rowley JD
    N Engl J Med; 1990 Jan; 322(2):77-82. PubMed ID: 2294436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma.
    Iolascon A; Faienza MF; Coppola B; Rosolen A; Basso G; Della Ragione F; Schettini F
    Genes Chromosomes Cancer; 1996 Apr; 15(4):217-22. PubMed ID: 8703847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of the putative tumor suppressor gene p16/MTS1 in human hematological malignancies.
    Duro D; Flexor MA; Bernard O; d'Agay MF; Berger R; Larsen CJ
    C R Acad Sci III; 1994 Oct; 317(10):913-9. PubMed ID: 7882134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
    Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
    Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas.
    Otsuki T; Clark HM; Wellmann A; Jaffe ES; Raffeld M
    Cancer Res; 1995 Apr; 55(7):1436-40. PubMed ID: 7882348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.
    Dreyling MH; Bohlander SK; Le Beau MM; Olopade OI
    Blood; 1995 Sep; 86(5):1931-8. PubMed ID: 7544647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.
    Hangaishi A; Ogawa S; Imamura N; Miyawaki S; Miura Y; Uike N; Shimazaki C; Emi N; Takeyama K; Hirosawa S; Kamada N; Kobayashi Y; Takemoto Y; Kitani T; Toyama K; Ohtake S; Yazaki Y; Ueda R; Hirai H
    Blood; 1996 Jun; 87(12):4949-58. PubMed ID: 8652807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.